Case Study: Using Technology To Reduce Operational Burden In Clinical Research

In 2016, the Leukemia and Lymphoma Society (LLS) established the Beat AML® Master Trial with the aim of advancing the treatment paradigm for Acute Myeloid Leukemia (AML) through collaboration across over 20+ sites, sponsors, and technology vendors.

By deploying Flatiron’s clinical trial solutions, including Flatiron Clinical Pipe™, sites were able to transfer data with 100% accuracy over the course of the trial. Learn more about how LLS partnered with Flatiron to meet the high demands and standards for Beat AML®.